French SARS-CoV-2 guidelines for colon cancer patients: a Letter to the Editor

Written by Lauren Woolfe, Future Science Group

The latest Letter to the Editor published by Colorectal Cancer discusses the journal’s recently published Whitepaper outlining SARS-CoV-2 guidelines, strategies to reduce COVID-19 risk and maintain treatment benefits in colorectal cancer (CRC) care. In this letter, Juan O’Connor (Instituto Alexander Fleming, Buenos Aires, Argentina) supports the guidelines and suggests that compliance could be improved by using a practical and pragmatic solution offered by precision medicine in immuno-oncology. One of the early guidelines to protect cancer patients against the novel coronavirus (SARS-CoV-2) was developed in early March by the French High Council for Public Health, at the request of the French...

To view this content, please register now for access

It's completely free